Now Diagnostics Inc., which is known for our ADEXUSDx® product line in the US, is excited to announce that our over-the-counter (OTC) product line FIRST TO KNOW®, has recently received approval for OTC sales in Europe!
FIRST TO KNOW® is an easy to use, blood-based pregnancy test, that will detect pregnancy much sooner than urine-based pregnancy tests currently available OTC.
Giving women the option to know they’re pregnant sooner, coupled with the Global demand for a more sensitive, lab-accurate at home pregnancy test, made FIRST TO KNOW® the perfect fit for consumers in the European Market.
About NOW Diagnostics
NOW Diagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostics testing. Its ADEXUSDx® product line features a lab at your fingertip, using a drop of blood to test for a variety of common conditions, illnesses, and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOW Diagnostics has the potential to decrease the waiting period to determine test results by days. The company’s Springdale, Ark., facility was officially registered with the U.S. Food and Drug Administration in December 2014. The company is currently offering an hCG (pregnancy) test in the United States and Europe as well as three cardiac (heart attack) tests and three toxicology tests in Europe. For more information about NOW Diagnostics, visit www.nowdx.com.
NOW Diagnostics Company Contact
Jeff Ellis, VP Sales & Marketing
NOW Diagnostics Media Contact
Armada Medical Marketing